Clinical Trials Browser

Phase 2 × Breast Neoplasms × G(M1) Ganglioside × Clear all

NCT05751668 2026-04-07

Finding an Effective Dose of GM1 to Reduce or Prevent Neuropathy (Numbness or Weakness) Due to Treatment With Paclitaxel (Phase II)

Phase 2 Suspended

Breast Neoplasms